Drug Information

Drug General Information
Drug ID
D04BWH
Former ID
DNC013847
Drug Name
Benzo[b]thiophen-2-ylboronic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529114]
Formula
C8H7BO2S
Canonical SMILES
B(C1=CC2=CC=CC=C2S1)(O)O
InChI
1S/C8H7BO2S/c10-9(11)8-5-6-3-1-2-4-7(6)12-8/h1-5,10-11H
InChIKey
YNCYPMUJDDXIRH-UHFFFAOYSA-N
PubChem Compound ID
2359
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529790]
Beta-lactamase Target Info Inhibitor [529114]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529114J Med Chem. 2007 Nov 15;50(23):5644-54. Epub 2007 Oct 23.Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy.
Ref 529114J Med Chem. 2007 Nov 15;50(23):5644-54. Epub 2007 Oct 23.Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy.
Ref 529790J Med Chem. 2008 Nov 27;51(22):7057-60.Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.